Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Strides Pharma Strides Pharma Science Ltd. | BSE 950.90 -22.90 (-2.35%) | NSE 943.55 -30.40 (-3.12%) | Trade | Add

BSE Live

Nov 14, 16:01

950.90 -22.90 (-2.35%)

Volume

AVERAGE VOLUME

5-Day

79,299

10-Day

121,620

30-Day

48,365

17,415

Prev. Close

973.80
Open Price

974.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 14, 15:59

943.55 -30.40 (-3.12%)

Volume

AVERAGE VOLUME

5-Day

543,770

10-Day

1,854,170

30-Day

813,907

374,713

Prev. Close

973.95
Open Price

973.95

Bid Price (Qty.)
943.55 (1053)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Strides Pharma Science (in Rs. Cr.)	Mar 15	Mar 14	Dec 12	Dec 11	Dec 10
Per Share Ratios
Basic EPS (Rs.)	141.85	298.56	144.30	38.65	23.52
Diluted EPS (Rs.)	141.27	297.30	131.85	38.32	23.52
Cash EPS (Rs.)	152.38	306.18	162.71	57.95	37.83
Book Value [ExclRevalReserve]/Share (Rs.)	195.19	181.73	356.79	242.88	269.33
Book Value [InclRevalReserve]/Share (Rs.)	195.19	181.73	356.79	242.88	269.33
Revenue from Operations/Share (Rs.)	200.59	225.12	392.38	436.80	293.66
PBDIT/Share (Rs.)	44.86	47.62	100.96	89.47	68.25
PBIT/Share (Rs.)	34.12	38.14	82.34	71.61	57.19
PBT/Share (Rs.)	24.92	15.40	161.47	46.71	33.53
Net Profit/Share (Rs.)	141.64	296.70	144.10	40.08	26.76
NP After MI And SOA / Share (Rs.)	141.74	296.60	143.91	38.45	23.52
Profitability Ratios
PBDIT Margin (%)	22.36	21.15	25.72	20.48	23.24
PBIT Margin (%)	17.00	16.94	20.98	16.39	19.47
PBT Margin (%)	12.42	6.84	41.15	10.69	11.41
Net Profit Margin (%)	70.61	131.79	36.72	9.17	9.11
NP After MI And SOA Margin (%)	70.66	131.75	36.67	8.80	8.00
Return on Networth/Equity (%)	73.80	175.47	41.76	16.36	10.58
Return on Capital Employed (%)	57.63	152.85	28.20	8.72	4.60
Return on Assets (%)	33.98	84.17	17.63	4.18	3.02
Total Debt/Equity (X)	0.41	0.26	0.66	1.27	1.57
Asset Turnover Ratio (%)	48.10	63.88	48.09	47.53	37.73
Liquidity Ratios
Current Ratio (X)	1.40	1.39	0.79	0.58	1.27
Quick Ratio (X)	1.20	1.20	0.54	0.41	1.07
Inventory Turnover Ratio (X)	5.76	7.62	5.22	5.31	5.44
Dividend Payout Ratio (NP) (%)	76.13	170.30	1.39	5.22	6.74
Dividend Payout Ratio (CP) (%)	70.77	165.03	1.23	3.56	4.58
Earnings Retention Ratio (%)	23.87	-70.30	98.61	94.78	93.26
Cash Earnings Retention Ratio (%)	29.23	-65.03	98.77	96.44	95.42
Coverage Ratios
Interest Coverage Ratios (%)	4.29	2.09	2.50	2.15	2.42
Interest Coverage Ratios (Post Tax) (%)	4.29	2.09	2.50	2.15	2.42
Valuation Ratios
Enterprise Value (Cr.)	7,367.99	2,417.78	7,683.54	3,866.74	4,535.32
EV/Net Operating Revenue (X)	6.16	1.80	3.33	1.52	2.67
EV/EBITDA (X)	27.55	8.52	12.94	7.40	11.51
MarketCap/Net Operating Revenue (X)	5.88	1.72	2.79	0.92	1.53
Retention Ratios (%)	23.86	-70.30	98.60	94.77	93.25
Price/BV (X)	6.14	2.29	3.18	1.71	2.02
Price/Net Operating Revenue	5.88	1.72	2.79	0.92	1.53
Earnings Yield	0.12	0.77	0.13	0.10	0.05